Kimberly-Clark has submitted a US$48.7bn cash and stock deal to acquire Kenvue, pushing two global consumer health brands into one of the largest mergers in the sector

While the financial structure has gained unanimous board approval and impressed shareholders, the real complexity sits in the supply chain. Both companies operate with expansive

 logistics systems, regional regulations and manufacturing strategies that now need to align without delay or disruption.